Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin Signaling
Nicholas C. DeVito(Duke Medical Center), Brent A. Hanks(Duke University)
Cited by 1
Related Papers
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy
|Journal of Clinical Investigation|2020|248
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
|Journal for ImmunoTherapy of Cancer|2017|239
Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy
|Cancer Immunology Research|2015|178
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy
|Science Translational Medicine|2022|53